TY - STD TI - Generic Drugs.http://www.who.int/trade/glossary/story034/en/index.html, UR - http://www.who.int/trade/glossary/story034/en/index.html ID - ref1 ER - TY - JOUR AU - Birkett, D. J. PY - 2003 DA - 2003// TI - Generics – equal or not? JO - Aust Prescr VL - 26 UR - https://doi.org/10.18773/austprescr.2003.063 DO - 10.18773/austprescr.2003.063 ID - Birkett2003 ER - TY - STD TI - FDA basics - Drugs.http://www.fda.gov/AboutFDA/Transparency/Basics/ucm192696.htm, UR - http://www.fda.gov/AboutFDA/Transparency/Basics/ucm192696.htm ID - ref3 ER - TY - STD TI - Approval of Generic Drugs.http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm127615.pdf, UR - http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm127615.pdf ID - ref4 ER - TY - STD TI - Understanding Generic Drugs.http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingGenericDrugs/default.htm, UR - http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingGenericDrugs/default.htm ID - ref5 ER - TY - STD TI - Hatch-Waxman Act summary [Drug Price Competition and Patent Term Restoration Act of. 1984,http://thomas.loc.gov/cgi-bin/bdquery/z?d098:SN01538:@@@L&summ2=m&, ], UR - http://thomas.loc.gov/cgi-bin/bdquery/z?d098:SN01538:@@@L&summ2=m& ID - ref6 ER - TY - STD TI - Office of Generic Drugs presentation.http://www.fda.gov/downloads/AboutFDA/Transparency/Basics/UCM226568.pdf, UR - http://www.fda.gov/downloads/AboutFDA/Transparency/Basics/UCM226568.pdf ID - ref7 ER - TY - STD TI - Generic Drugs: Overview of ANDA Review Process.http://www.fda.gov/downloads/Drugs/NewsEvents/UCM167310.pdf, UR - http://www.fda.gov/downloads/Drugs/NewsEvents/UCM167310.pdf ID - ref8 ER - TY - JOUR AU - Simoens, S. PY - 2007 DA - 2007// TI - International comparison of generic medicine prices JO - Curr Med Res Opin VL - 23 UR - https://doi.org/10.1185/030079907X233395 DO - 10.1185/030079907X233395 ID - Simoens2007 ER - TY - STD TI - What Are Generic Drugs?.http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingGenericDrugs/ucm144456.htm, UR - http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingGenericDrugs/ucm144456.htm ID - ref10 ER - TY - STD TI - US-FDA: Guidance for Industry - Bioavailability and Bioequivalence. FDA Guidances for Industry. ID - ref11 ER - TY - STD TI - Process for Approving Generic Drugs.http://www.fda.gov/Training/ForHealthProfessionals/ucm090215.htm, UR - http://www.fda.gov/Training/ForHealthProfessionals/ucm090215.htm ID - ref12 ER - TY - JOUR AU - Kesselheim, A. S. AU - Misono, A. S. AU - Lee, J. L. AU - Stedman, M. R. AU - Brookhart, M. A. AU - Choudhry, N. K. AU - Shrank, W. H. PY - 2008 DA - 2008// TI - Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis JO - JAMA VL - 300 UR - https://doi.org/10.1001/jama.2008.758 DO - 10.1001/jama.2008.758 ID - Kesselheim2008 ER - TY - JOUR AU - Davit, B. M. AU - Nwakama, P. E. AU - Buehler, G. J. AU - Conner, D. P. AU - Haidar, S. H. AU - Patel, D. T. AU - Yang, Y. AU - Yu, L. X. AU - Woodcock, J. PY - 2009 DA - 2009// TI - Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration JO - Ann Pharmacother VL - 43 UR - https://doi.org/10.1345/aph.1M141 DO - 10.1345/aph.1M141 ID - Davit2009 ER - TY - JOUR AU - Patel, V. AU - Cordato, D. J. AU - Dias, M. AU - Beran, R. G. PY - 2012 DA - 2012// TI - Changed constitution without change in brand name–the risk of generics in epilepsy JO - Epilepsy Res VL - 98 UR - https://doi.org/10.1016/j.eplepsyres.2011.09.019 DO - 10.1016/j.eplepsyres.2011.09.019 ID - Patel2012 ER - TY - STD TI - EMA Q&A on Generic Medicine.http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/11/WC500012382.pdf, UR - http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/11/WC500012382.pdf ID - ref16 ER - TY - STD TI - EU Authorisation Procedures.http://ec.europa.eu/health/authorisation-procedures_en.htm, UR - http://ec.europa.eu/health/authorisation-procedures_en.htm ID - ref17 ER - TY - STD TI - The Centralised Procedure.http://ec.europa.eu/health/authorisation-procedures-centralised_en.htm, UR - http://ec.europa.eu/health/authorisation-procedures-centralised_en.htm ID - ref18 ER - TY - STD TI - The Mutual Recognition Procedure.http://ec.europa.eu/health/authorisation-procedures-mutual-recognition_en.htm, UR - http://ec.europa.eu/health/authorisation-procedures-mutual-recognition_en.htm ID - ref19 ER - TY - STD TI - The Decentralised Procedure.http://ec.europa.eu/health/authorisation-procedures-decentralised_en.htm, UR - http://ec.europa.eu/health/authorisation-procedures-decentralised_en.htm ID - ref20 ER - TY - STD TI - Directive. 2001,http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32001L0083:EN:HTML, /83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, UR - http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32001L0083:EN:HTML ID - ref21 ER - TY - STD TI - Notice to Applicants Volume 2A Procedures for marketing authorisation.http://ec.europa.eu/health/files/eudralex/vol-2/a/vol2a_chap1_2005-11_en.pdf, UR - http://ec.europa.eu/health/files/eudralex/vol-2/a/vol2a_chap1_2005-11_en.pdf ID - ref22 ER - TY - STD TI - Marketing Authorisation Process for Generic Medicines.http://198.170.119.137/gen-authorisation.htm, UR - http://198.170.119.137/gen-authorisation.htm ID - ref23 ER - TY - CHAP PY - 2010 DA - 2010// TI - Guideline on the Investigation of Bioequivalence BT - European Medicines Agency website ID - ref24 ER - TY - JOUR AU - McGinn, D. AU - Godman, B. AU - Lonsdale, J. AU - Way, R. AU - Wettermark, B. AU - Haycox, A. PY - 2010 DA - 2010// TI - Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications JO - Expert Rev Pharmacoecon Outcomes Res VL - 10 UR - https://doi.org/10.1586/erp.09.73 DO - 10.1586/erp.09.73 ID - McGinn2010 ER - TY - JOUR AU - Dylst, P. AU - Vulto, A. AU - Simoens, S. PY - 2011 DA - 2011// TI - The impact of reference-pricing systems in Europe: a literature review and case studies JO - Expert Rev Pharmacoecon Outcomes Res VL - 11 UR - https://doi.org/10.1586/erp.11.70 DO - 10.1586/erp.11.70 ID - Dylst2011 ER - TY - JOUR AU - Godman, B. AU - Shrank, W. AU - Andersen, M. AU - Berg, C. AU - Bishop, I. AU - Burkhardt, T. AU - Garuoliene, K. AU - Herholz, H. AU - Joppi, R. AU - Kalaba, M. PY - 2010 DA - 2010// TI - Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications JO - Expert Rev Pharmacoecon Outcomes Res VL - 10 UR - https://doi.org/10.1586/erp.10.72 DO - 10.1586/erp.10.72 ID - Godman2010 ER - TY - JOUR AU - Puig-Junoy, J. PY - 2010 DA - 2010// TI - Impact of European pharmaceutical price regulation on generic price competition: a review JO - PharmacoEconomics VL - 28 UR - https://doi.org/10.2165/11535360-000000000-00000 DO - 10.2165/11535360-000000000-00000 ID - Puig-Junoy2010 ER - TY - JOUR AU - Godman, B. AU - Shrank, W. AU - Wettermark, B. AU - Andersen, M. AU - Bishop, I. AU - Burkhardt, T. AU - Garuolienè, K. AU - Kalaba, M. AU - Laius, O. AU - Joppi, R. PY - 2010 DA - 2010// TI - Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe? JO - Pharmaceuticals VL - 3 UR - https://doi.org/10.3390/ph3082470 DO - 10.3390/ph3082470 ID - Godman2010 ER - TY - JOUR AU - Simoens, S. PY - 2008 DA - 2008// TI - Generic medicine pricing in Europe: current issues and future perspective JO - J Med Econ VL - 11 UR - https://doi.org/10.3111/13696990801939716 DO - 10.3111/13696990801939716 ID - Simoens2008 ER - TY - STD TI - European Generic Medicines Association - Healthcare Economics.http://198.170.119.137/gen-economics.htm, UR - http://198.170.119.137/gen-economics.htm ID - ref31 ER - TY - STD TI - Why do medications have brand names and generic names?.http://www.nhs.uk/chq/Pages/1003.aspx?CategoryID=73&SubCategoryID=108, UR - http://www.nhs.uk/chq/Pages/1003.aspx?CategoryID=73&SubCategoryID=108 ID - ref32 ER - TY - BOOK AU - Sinclair, U. PY - 1906 DA - 1906// TI - The Jungle PB - Doubleday CY - Compan ID - Sinclair1906 ER - TY - STD TI - 100 Years of Protecting and Promoting Women's Health.http://www.fda.gov/ForConsumers/ByAudience/ForWomen/ucm118458.htm, UR - http://www.fda.gov/ForConsumers/ByAudience/ForWomen/ucm118458.htm ID - ref34 ER - TY - STD TI - Milestones in U.S. Food and Drug Law History.http://www.fda.gov/AboutFDA/WhatWeDo/History/Milestones/default.htm, UR - http://www.fda.gov/AboutFDA/WhatWeDo/History/Milestones/default.htm ID - ref35 ER - TY - STD TI - What Are "Biologics" Questions and Answers.http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CBER/ucm133077.htm, UR - http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CBER/ucm133077.htm ID - ref36 ER - TY - STD TI - Biosimilars.http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/default.htm, UR - http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/default.htm ID - ref37 ER - TY - STD TI - Official Journal of the European Union. Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products. 1965, Eur-Lex: The Council Of The European Communities ID - ref38 ER - TY - STD TI - Pharmaceuticals In The European Union.http://ec.europa.eu/enterprise/newsroom/cf/_getdocument.cfm?doc_id=1684, UR - http://ec.europa.eu/enterprise/newsroom/cf/_getdocument.cfm?doc_id=1684 ID - ref39 ER - TY - STD TI - Official Journal of the European Union. Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products. 1975, Eur-Lex: The Council Of The European Communities ID - ref40 ER - TY - STD TI - Official Journal of the European Union. Second Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products. 1975, Eur-Lex: The Council Of The European Communities ID - ref41 ER - TY - STD TI - Official Journal of the European Union. Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products. 1993, Eur-Lex: The Council Of The European Communities ID - ref42 ER - TY - STD TI - Official Journal of the European Union. Council Directive 93/41/EEC of 14 June 1993 repealing Directive 87/22/EEC on the approximation of national measures relating to the placing on the market of high- technology medicinal products, particularly those derived from biotechnology. 1993, Eur-Lex: The Council Of The European Communities ID - ref43 ER - TY - STD TI - New visual identity, web/e-mail addresses and organisation chart of the European Medicines Agency.http://www.epha.org/IMG/pdf/EMEA_Communication_NewVisiualIdentity_en.pdf, UR - http://www.epha.org/IMG/pdf/EMEA_Communication_NewVisiualIdentity_en.pdf ID - ref44 ER - TY - STD TI - Directive. 2011,http://ec.europa.eu/health/files/eudralex/vol-1/dir_2011_62/dir_2011_62_en.pdf, /62/EU Of The European Parliament And Of The Council Of 8 June 2011 Amending Directive 2001/83/EC On The Community Code Relating To Medicinal Products For Human Use, As Regards The Prevention Of The Entry Into The Legal Supply Chain Of Falsified Medicinal Products, UR - http://ec.europa.eu/health/files/eudralex/vol-1/dir_2011_62/dir_2011_62_en.pdf ID - ref45 ER - TY - STD TI - Falsified medicines.http://ec.europa.eu/health/human-use/falsified_medicines/index_en.htm, UR - http://ec.europa.eu/health/human-use/falsified_medicines/index_en.htm ID - ref46 ER - TY - STD TI - FAQ on Biosimilar Medicines.http://www.egagenerics.com/index.php/biosimilar-medicines/faq-on-biosimilars, UR - http://www.egagenerics.com/index.php/biosimilar-medicines/faq-on-biosimilars ID - ref47 ER - TY - STD TI - Questions and Answers on biosimilar medicines (similar biological medicinal products).http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/12/WC500020062.pdf, UR - http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/12/WC500020062.pdf ID - ref48 ER - TY - STD TI - European Public Assessment Reports.http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fmedicines%2Flanding%2Fepar_search.jsp&murl=menus%2Fmedicines%2Fmedicines.jsp&mid=WC0b01ac058001d124&searchTab=searchByAuthType&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keyword=Enter+keywords&searchType=name&taxonomyPath=&treeNumber=&searchGenericType=biosimilars&genericsKeywordSearch=Submit&jsenabled=true, UR - http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fmedicines%2Flanding%2Fepar_search.jsp&murl=menus%2Fmedicines%2Fmedicines.jsp&mid=WC0b01ac058001d124&searchTab=searchByAuthType&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keyword=Enter+keywords&searchType=name&taxonomyPath=&treeNumber=&searchGenericType=biosimilars&genericsKeywordSearch=Submit&jsenabled=true ID - ref49 ER - TY - JOUR AU - DiMasi, J. A. AU - Grabowski, H. G. PY - 2007 DA - 2007// TI - The cost of biopharmaceutical R&D: is biotech different? JO - Manag Decis Econ VL - 28 UR - https://doi.org/10.1002/mde.1360 DO - 10.1002/mde.1360 ID - DiMasi2007 ER - TY - JOUR AU - DiMasi, J. PY - 2001 DA - 2001// TI - Risks in new drug develoopment: Approval success rates for investigational drugs JO - Clin Pharmacol Ther VL - 69 UR - https://doi.org/10.1067/mcp.2001.115446 DO - 10.1067/mcp.2001.115446 ID - DiMasi2001 ER - TY - STD TI - New Drug Development and Review Process.http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm053131.htm, UR - http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm053131.htm ID - ref52 ER - TY - STD TI - Guidance on the establishment of new INN stems.http://www.who.int/medicines/services/inn/StemBook_2011_Final.pdf, UR - http://www.who.int/medicines/services/inn/StemBook_2011_Final.pdf ID - ref53 ER - TY - JOUR AU - Kesselheim, A. S. AU - Stedman, M. R. AU - Bubrick, E. J. AU - Gagne, J. J. AU - Misono, A. S. AU - Lee, J. L. AU - Brookhart, M. A. AU - Avorn, J. AU - Shrank, W. H. PY - 2010 DA - 2010// TI - Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs: A Systematic Review and Meta-Analysis JO - Drugs VL - 70 UR - https://doi.org/10.2165/10898530-000000000-00000 DO - 10.2165/10898530-000000000-00000 ID - Kesselheim2010 ER - TY - JOUR AU - Amit, G. AU - Rosen, A. AU - Wagshal, A. B. AU - Bonneh, D. Y. AU - Liss, T. AU - Grosbard, A. AU - Ilia, R. AU - Katz, A. PY - 2004 DA - 2004// TI - Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillation JO - Am J Cardiol VL - 93 UR - https://doi.org/10.1016/j.amjcard.2004.02.071 DO - 10.1016/j.amjcard.2004.02.071 ID - Amit2004 ER - TY - JOUR AU - Araszkiewicz, A. A. AU - Szabert, K. AU - Godman, B. AU - Wladysiuk, M. AU - Barbui, C. AU - Haycox, A. PY - 2008 DA - 2008// TI - Generic olanzapine: health authority opportunity or nightmare? JO - Expert Rev Pharmacoecon Outcomes Res VL - 8 UR - https://doi.org/10.1586/14737167.8.6.549 DO - 10.1586/14737167.8.6.549 ID - Araszkiewicz2008 ER - TY - JOUR AU - Alessi-Severini, S. AU - Honcharik, P. L. AU - Simpson, K. D. AU - Eleff, M. K. AU - Collins, D. M. PY - 2006 DA - 2006// TI - Evaluation of an interchangeability switch in patients treated with clozapine: A retrospective review JO - J Clin Psychiatr VL - 67 UR - https://doi.org/10.4088/JCP.v67n0706 DO - 10.4088/JCP.v67n0706 ID - Alessi-Severini2006 ER - TY - JOUR AU - Paton, C. PY - 2006 DA - 2006// TI - Generic clozapine: outcomes after switching formulations JO - Br J Psychiatr J Mental Sci VL - 189 UR - https://doi.org/10.1192/bjp.bp.105.017079 DO - 10.1192/bjp.bp.105.017079 ID - Paton2006 ER - TY - JOUR AU - Bulsara, C. AU - McKenzie, A. AU - Sanfilippo, F. AU - Holman, C. D. J. AU - Emery, J. E. PY - 2010 DA - 2010// TI - ‘Not the full Monty’: a qualitative study of seniors’ perceptions of generic medicines in Western Australia JO - Aust J Prim Health VL - 16 UR - https://doi.org/10.1071/PY10006 DO - 10.1071/PY10006 ID - Bulsara2010 ER - TY - JOUR AU - Hassali, M. A. A. AU - Shafie, A. A. AU - Jamshed, S. AU - Ibrahim, M. I. M. AU - Awaisu, A. PY - 2009 DA - 2009// TI - Consumers' views on generic medicines: A review of the literature JO - Int J Pharm Pract VL - 17 ID - Hassali2009 ER - TY - JOUR AU - Figueiras, M. J. AU - Cortes, M. A. AU - Marcelino, D. AU - Weinman, J. PY - 2010 DA - 2010// TI - Lay views about medicines: the influence of the illness label for the use of generic versus brand JO - Psychol Health VL - 25 UR - https://doi.org/10.1080/08870440903137170 DO - 10.1080/08870440903137170 ID - Figueiras2010 ER - TY - JOUR AU - Babar, Z. U. AU - Grover, P. AU - Stewart, J. AU - Hogg, M. AU - Short, L. AU - Seo, H. G. AU - Rew, A. PY - 2011 DA - 2011// TI - Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand JO - Res Soc Admin Pharm RSAP VL - 7 UR - https://doi.org/10.1016/j.sapharm.2010.06.004 DO - 10.1016/j.sapharm.2010.06.004 ID - Babar2011 ER - TY - JOUR AU - Quintal, C. AU - Mendes, P. PY - 2012 DA - 2012// TI - Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists JO - Health Pol (Amsterdam, Netherlands) VL - 104 UR - https://doi.org/10.1016/j.healthpol.2011.10.001 DO - 10.1016/j.healthpol.2011.10.001 ID - Quintal2012 ER - TY - JOUR AU - Heikkila, R. AU - Mantyselka, P. AU - Ahonen, R. PY - 2011 DA - 2011// TI - Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland JO - Pharmacoepidemiol Drug Saf VL - 20 UR - https://doi.org/10.1002/pds.2084 DO - 10.1002/pds.2084 ID - Heikkila2011 ER - TY - JOUR AU - Heikkila, R. AU - Mantyselka, P. AU - Ahonen, R. PY - 2011 DA - 2011// TI - Price, familiarity, and availability determine the choice of drug - a population-based survey five years after generic substitution was introduced in Finland JO - BMC Clin Pharmacol VL - 11 UR - https://doi.org/10.1186/1472-6904-11-20 DO - 10.1186/1472-6904-11-20 ID - Heikkila2011 ER - TY - JOUR AU - Graedon, J. AU - Graedon, T. PY - 2008 DA - 2008// TI - Are Generic Drugs Safe? JO - Prevention (Emmaus, Pa) VL - 175 ID - Graedon2008 ER - TY - JOUR AU - Ringe, J. D. AU - Moller, G. PY - 2009 DA - 2009// TI - Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis JO - Rheumatol Int VL - 30 UR - https://doi.org/10.1007/s00296-009-0940-5 DO - 10.1007/s00296-009-0940-5 ID - Ringe2009 ER - TY - JOUR AU - Kanis, J. A. AU - Reginster, J. Y. AU - Kaufman, J. M. AU - Ringe, J. D. AU - Adachi, J. D. AU - Hiligsmann, M. AU - Rizzoli, R. AU - Cooper, C. PY - 2012 DA - 2012// TI - A reappraisal of generic bisphosphonates in osteoporosis JO - Osteoporos Int J Established Result Cooperat Between Eur Found Osteoporos Nat Osteoporos Found USA VL - 23 UR - https://doi.org/10.1007/s00198-011-1796-6 DO - 10.1007/s00198-011-1796-6 ID - Kanis2012 ER - TY - JOUR AU - Diez-Perez, A. AU - Adachi, J. D. AU - Agnusdei, D. AU - Bilezikian, J. P. AU - Compston, J. E. AU - Cummings, S. R. AU - Eastell, R. AU - Eriksen, E. F. AU - Gonzalez-Macias, J. AU - Liberman, U. A. PY - 2012 DA - 2012// TI - Treatment failure in osteoporosis JO - Osteoporos Int J Established Result Cooperat Between Eur Found Osteoporos Nat Osteoporos Found USA VL - 23 UR - https://doi.org/10.1007/s00198-012-2093-8 DO - 10.1007/s00198-012-2093-8 ID - Diez-Perez2012 ER - TY - JOUR AU - Privitera, M. D. PY - 2008 DA - 2008// TI - Generic Antiepileptic Drugs: Current Controversies and Future Directions JO - Epilepsy Curr VL - 8 UR - https://doi.org/10.1111/j.1535-7511.2008.00261.x DO - 10.1111/j.1535-7511.2008.00261.x ID - Privitera2008 ER - TY - JOUR AU - Jain, K. PY - 1993 DA - 1993// TI - Investigation and management of loss of efficacy of an antiepileptic medication using carbamazepine as an example JO - J R Soc Med VL - 86 ID - Jain1993 ER - TY - JOUR AU - Mayer, T. AU - May, T. W. AU - Altenmuller, D. M. AU - Sandmann, M. AU - Wolf, P. PY - 1999 DA - 1999// TI - Clinical Problems with Generic Antiepileptic Drugs: Comparison of Sustained-Release Formulations of Carbamazepine JO - Clin Drug Investig VL - 18 UR - https://doi.org/10.2165/00044011-199918010-00003 DO - 10.2165/00044011-199918010-00003 ID - Mayer1999 ER - TY - JOUR AU - Crawford, P. AU - Feely, M. AU - Guberman, A. AU - Kramer, G. PY - 2006 DA - 2006// TI - Are there potential problems with generic substitution of antiepileptic drugs?: A review of issues JO - Seizure VL - 15 UR - https://doi.org/10.1016/j.seizure.2005.12.010 DO - 10.1016/j.seizure.2005.12.010 ID - Crawford2006 ER - TY - JOUR AU - Ferner, R. E. AU - Lenney, W. AU - Marriott, J. F. PY - 2010 DA - 2010// TI - Controversy over generic substitution JO - BMJ (Clin Res ed) VL - 340 UR - https://doi.org/10.1136/bmj.c2548 DO - 10.1136/bmj.c2548 ID - Ferner2010 ER - TY - JOUR AU - Shrank, W. H. AU - Liberman, J. N. AU - Fischer, M. A. AU - Girdish, C. AU - Brennan, T. A. AU - Choudhry, N. K. PY - 2011 DA - 2011// TI - Physician perceptions about generic drugs JO - Ann Pharmacother VL - 45 UR - https://doi.org/10.1345/aph.1P389 DO - 10.1345/aph.1P389 ID - Shrank2011 ER - TY - JOUR AU - Shrank, W. H. AU - Cox, E. R. AU - Fischer, M. A. AU - Mehta, J. AU - Choudhry, N. K. PY - 2009 DA - 2009// TI - Patients' perceptions of generic medications JO - Health Aff (Millwood) VL - 28 UR - https://doi.org/10.1377/hlthaff.28.2.546 DO - 10.1377/hlthaff.28.2.546 ID - Shrank2009 ER - TY - JOUR AU - Talati, R. AU - Scholle, J. M. AU - Phung, O. P. AU - Baker, E. L. AU - Baker, W. L. AU - Ashaye, A. AU - Kluger, J. AU - Coleman, C. I. AU - White, C. M. PY - 2012 DA - 2012// TI - Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review JO - Pharmacotherapy VL - 32 UR - https://doi.org/10.1002/j.1875-9114.2012.01099.x DO - 10.1002/j.1875-9114.2012.01099.x ID - Talati2012 ER - TY - JOUR AU - Johnston, A. PY - 2010 DA - 2010// TI - Challenges of therapeutic substitution of drugs for economic reasons: focus on CVD prevention JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007990903578462 DO - 10.1185/03007990903578462 ID - Johnston2010 ER - TY - JOUR AU - Johnston, A. AU - Stafylas, P. AU - Stergiou, G. S. PY - 2010 DA - 2010// TI - Effectiveness, safety and cost of drug substitution in hypertension JO - Br J Clin Pharmacol VL - 70 UR - https://doi.org/10.1111/j.1365-2125.2010.03681.x DO - 10.1111/j.1365-2125.2010.03681.x ID - Johnston2010 ER - TY - JOUR AU - Duerden, M. G. AU - Hughes, D. A. PY - 2010 DA - 2010// TI - Generic and therapeutic substitutions in the UK: are they a good thing? JO - Br J Clin Pharmacol VL - 70 UR - https://doi.org/10.1111/j.1365-2125.2010.03718.x DO - 10.1111/j.1365-2125.2010.03718.x ID - Duerden2010 ER - TY - JOUR AU - Simoens, S. PY - 2011 DA - 2011// TI - Generic and therapeutic substitution: ethics meets health economics JO - Int J Clin Pharm VL - 33 UR - https://doi.org/10.1007/s11096-011-9500-7 DO - 10.1007/s11096-011-9500-7 ID - Simoens2011 ER - TY - JOUR AU - Johnston, A. AU - Asmar, R. AU - Dahlof, B. AU - Hill, K. AU - Jones, D. A. AU - Jordan, J. AU - Livingston, M. AU - Macgregor, G. AU - Sobanja, M. AU - Stafylas, P. PY - 2011 DA - 2011// TI - Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe JO - Br J Clin Pharmacol VL - 72 UR - https://doi.org/10.1111/j.1365-2125.2011.03987.x DO - 10.1111/j.1365-2125.2011.03987.x ID - Johnston2011 ER - TY - JOUR AU - Fusier, I. AU - Tollier, C. AU - Husson, M. C. PY - 2003 DA - 2003// TI - Medicines containing pharmaceutical excipients with known effects: a French review JO - Pharm World Sci PWS VL - 25 UR - https://doi.org/10.1023/A:1024815412228 DO - 10.1023/A:1024815412228 ID - Fusier2003 ER - TY - JOUR AU - Mumoli, N. AU - Cei, M. AU - Luschi, R. AU - Carmignani, G. AU - Camaiti, A. PY - 2011 DA - 2011// TI - Allergic reaction to Croscarmellose sodium used as excipient of a generic drug JO - QJM VL - 104 UR - https://doi.org/10.1093/qjmed/hcq175 DO - 10.1093/qjmed/hcq175 ID - Mumoli2011 ER - TY - JOUR AU - Reiffel, J. A. PY - 2000 DA - 2000// TI - Formulation Substitution and Other Pharmacokinetic Variability: Underappreciated Variables Affecting Antiarrhythmic Efficacy and Safety in Clinical Practice JO - Am J Cardiol VL - 85 UR - https://doi.org/10.1016/S0002-9149(00)00906-1 DO - 10.1016/S0002-9149(00)00906-1 ID - Reiffel2000 ER - TY - JOUR AU - Coloe, J. AU - Zirwas, M. J. PY - 2008 DA - 2008// TI - Allergens in corticosteroid vehicles JO - Dermatitis Contact Atopic Occup Drug Offic J Am Contact Dermatitis Soc North American Contact Dermatitis Group VL - 19 ID - Coloe2008 ER - TY - JOUR AU - Laroche, M. L. AU - Traore, H. AU - Merle, L. AU - Gaulier, J. M. AU - Viana, M. AU - Preux, P. M. PY - 2005 DA - 2005// TI - Quality of phenobarbital solid-dosage forms in the urban community of Nouakchott (Mauritania) JO - Epilepsia VL - 46 UR - https://doi.org/10.1111/j.1528-1167.2005.01805.x DO - 10.1111/j.1528-1167.2005.01805.x ID - Laroche2005 ER - TY - BOOK AU - Fauci, A. S. AU - Harrison, T. R. PY - 2008 DA - 2008// TI - Harrison's principles of internal medicine PB - McGraw-Hill Medical CY - New York; London ID - Fauci2008 ER - TY - STD TI - Generic substitution terminated for oral medicines containing cyclosporine or tacrolimus.http://laegemiddelstyrelsen.dk/en/topics/authorisation-and-supervision/licensing-of-medicines/news/generic-substitution-terminated-for-oral--tacrolimus, UR - http://laegemiddelstyrelsen.dk/en/topics/authorisation-and-supervision/licensing-of-medicines/news/generic-substitution-terminated-for-oral--tacrolimus ID - ref89 ER - TY - STD TI - British Medical Association and the Royal Pharmaceutical Society of Great Britain: British National Formulary. 2012, BMJ Publishing Group, 63 ID - ref90 ER - TY - STD TI - Items Unsuitable for Generic Prescribing.http://www.nhssb.n-i.nhs.uk/prescribing/documents/RegionalListGenericExceptionsJul08.pdf, UR - http://www.nhssb.n-i.nhs.uk/prescribing/documents/RegionalListGenericExceptionsJul08.pdf ID - ref91 ER - TY - STD TI - OECD Health Data. 2012,http://www.oecd.org/health/healthpoliciesanddata/oecdhealthdata2012-frequentlyrequesteddata.htm, - Frequently Requested Data, UR - http://www.oecd.org/health/healthpoliciesanddata/oecdhealthdata2012-frequentlyrequesteddata.htm ID - ref92 ER - TY - STD TI - Delivery of Pharmaceuticals in Ireland – Getting a Bigger Bang for the Buck.http://www.esri.ie/UserFiles/publications/RS24.pdf, UR - http://www.esri.ie/UserFiles/publications/RS24.pdf ID - ref93 ER - TY - STD TI - Generic Market Shares in Europe. 2006,http://198.170.119.137/doc/fac-GxMktEur_2006.pdf, UR - http://198.170.119.137/doc/fac-GxMktEur_2006.pdf ID - ref94 ER - TY - STD TI - Economies in Drug Usage in the Irish Healthcare Setting.http://www.dohc.ie/publications/pdf/economies_drug_usage.pdf?direct=1, UR - http://www.dohc.ie/publications/pdf/economies_drug_usage.pdf?direct=1 ID - ref95 ER - TY - STD TI - Generic Drug Utilisation In Ireland In. 2008,http://www.ncpe.ie/u_docs/doc_163.pdf, UR - http://www.ncpe.ie/u_docs/doc_163.pdf ID - ref96 ER - TY - STD TI - Finance Shared Services Primary Care Reimbursement Service: Statistical Analysis Of Claims And Payments. 2007,http://www.hse.ie/eng/Staff/PCRS/PCRS_Publications/2007_Report.pdf, UR - http://www.hse.ie/eng/Staff/PCRS/PCRS_Publications/2007_Report.pdf ID - ref97 ER - TY - JOUR AU - Tilson, L. AU - O'Leary, A. AU - Usher, C. AU - Barry, M. PY - 2010 DA - 2010// TI - Pharmacoeconomic Evaluation in Ireland JO - PharmacoEconomics VL - 28 UR - https://doi.org/10.2165/11318790-000000000-00000 DO - 10.2165/11318790-000000000-00000 ID - Tilson2010 ER - TY - JOUR AU - Tilson, L. AU - McGowan, B. AU - Ryan, M. AU - Barry, M. PY - 2003 DA - 2003// TI - Generic Drug Utilisation on the General Medical Services (GMS) Scheme in 2001 JO - Ir Med J VL - 96 ID - Tilson2003 ER - TY - STD TI - Generic Prescribing.http://www.stjames.ie/GPsHealthcareProfessionals/Newsletters/NMICBulletins/NMICBulletins2009/GenericbulletinNMICv15No1webwithefs.pdf, UR - http://www.stjames.ie/GPsHealthcareProfessionals/Newsletters/NMICBulletins/NMICBulletins2009/GenericbulletinNMICv15No1webwithrefs.pdf ID - ref100 ER - TY - BOOK AU - Gatyas, G. PY - 2011 DA - 2011// TI - IMS Institute Reports U.S. Spending on Medicines Grew 2.3 Percent in 2010, to $307.4 Billion. In: IMS Institute for Healthcare Informatics. IMS Website ID - Gatyas2011 ER - TY - STD TI - Prescriptions Dispensed in the Community: England, Statistics for. 2000,http://www.ic.nhs.uk/webfiles/publications/007_Primary_Care/Prescribing/Prescriptionsdispensedinthecommunity2000-2010/Prescriptions_Dispensed_2000_2010.pdf, to 2010, UR - http://www.ic.nhs.uk/webfiles/publications/007_Primary_Care/Prescribing/Prescriptionsdispensedinthecommunity2000-2010/Prescriptions_Dispensed_2000_2010.pdf ID - ref102 ER - TY - JOUR AU - Bennie, M. AU - Godman, B. AU - Bishop, I. AU - Campbell, S. PY - 2012 DA - 2012// TI - Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland JO - Expert Rev Pharmacoecon Outcomes Res VL - 12 UR - https://doi.org/10.1586/erp.11.98 DO - 10.1586/erp.11.98 ID - Bennie2012 ER - TY - JOUR AU - Godman, B. AU - Abuelkhair, M. AU - Vitry, A. AU - Abdu, S. PY - 2012 DA - 2012// TI - Payers endorse generics to enhance prescribing efficiency; impact and future implications, a case history approach JO - GABI VL - 1 ID - Godman2012 ER - TY - STD TI - Generic Drug Savings In The U.S. (Fourth Annual Edition. 2012,http://www.gphaonline.org/sites/default/files/IMSStudyAug2012WEB.pdf, UR - http://www.gphaonline.org/sites/default/files/IMSStudyAug2012WEB.pdf ID - ref105 ER - TY - BOOK PY - 2011 DA - 2011// TI - New Study Finds Use of Generic Prescription Drugs Saved Consumers and the U.S. Health Care System $931 Billion Over Past 10 Years ID - ref106 ER - TY - STD TI - Proposed Model for Reference Pricing and Generic Substitution.http://www.dohc.ie/publications/pdf/reference_pricing_generic_substitution.pdf?direct=1, UR - http://www.dohc.ie/publications/pdf/reference_pricing_generic_substitution.pdf?direct=1 ID - ref107 ER - TY - JOUR AU - Kanavos, P. PY - 2007 DA - 2007// TI - Do generics offer significant savings to the UK National Health Service? JO - Curr Med Res Opin VL - 23 UR - https://doi.org/10.1185/030079907X159506 DO - 10.1185/030079907X159506 ID - Kanavos2007 ER - TY - JOUR AU - Kanavos, P. AU - Taylor, D. PY - 2007 DA - 2007// TI - Pharmacy discounts on generic medicines in France: is there room for further efficiency savings? JO - Curr Med Res Opin VL - 23 UR - https://doi.org/10.1185/030079907X219571 DO - 10.1185/030079907X219571 ID - Kanavos2007 ER - TY - JOUR AU - Kanavos, P. AU - Costa-Font, J. AU - Seeley, E. PY - 2008 DA - 2008// TI - Competition in off-patent drug markets: Issues, regulation and evidence JO - Econ Pol VL - 23 UR - https://doi.org/10.1111/j.1468-0327.2008.00207.x DO - 10.1111/j.1468-0327.2008.00207.x ID - Kanavos2008 ER - TY - JOUR AU - Chandra, A. AU - Gruber, J. AU - McKnight, R. PY - 2010 DA - 2010// TI - Patient Cost-Sharing and Hospitalization Offsets in the Elderly JO - Am Econ Rev VL - 100 UR - https://doi.org/10.1257/aer.100.1.193 DO - 10.1257/aer.100.1.193 ID - Chandra2010 ER - TY - STD TI - IPHA Statement on the report on a Proposed Model for Reference Pricing and Generic Substitution.http://www.ipha.ie/news/latest-news.aspx?page=3&article=bfe9dcd0-7ae8-4f11-989a-875322ee8bc7, UR - http://www.ipha.ie/news/latest-news.aspx?page=3&article=bfe9dcd0-7ae8-4f11-989a-875322ee8bc7 ID - ref112 ER - TY - JOUR AU - Garuoliene, K. AU - Godman, B. AU - Gulbinovic, J. AU - Wettermark, B. AU - Haycox, A. PY - 2011 DA - 2011// TI - European countries with small populations can obtain low prices for drugs: Lithuania as a case history JO - Expert Rev Pharmacoecon Outcomes Res VL - 11 UR - https://doi.org/10.1586/erp.11.24 DO - 10.1586/erp.11.24 ID - Garuoliene2011 ER - TY - JOUR AU - Barron, D. PY - 2011 DA - 2011// TI - Concerns about generic substitution JO - Irish Medical News VL - 28 ID - Barron2011 ER - TY - JOUR AU - Hassali, M. A. AU - Kong, D. C. M. AU - Stewart, K. PY - 2004 DA - 2004// TI - Utilisation of generic medicines in the Australian healthcare system JO - J Generic Med VL - 2 UR - https://doi.org/10.1057/palgrave.jgm.4940051 DO - 10.1057/palgrave.jgm.4940051 ID - Hassali2004 ER - TY - JOUR AU - Scuderi, M. PY - 2002 DA - 2002// TI - Generic substitution in a Brisbane community pharmacy JO - Aust Pharm VL - 21 ID - Scuderi2002 ER - TY - JOUR AU - Andersson, K. AU - Sonesson, C. AU - Petzold, M. AU - Carlsten, A. AU - Lonnroth, K. PY - 2005 DA - 2005// TI - What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden JO - Pharmacoepidemiol Drug Saf VL - 14 UR - https://doi.org/10.1002/pds.1055 DO - 10.1002/pds.1055 ID - Andersson2005 ER - TY - JOUR AU - Andersson, K. A. AU - Petzold, M. G. AU - Allebeck, P. AU - Carlsten, A. PY - 2008 DA - 2008// TI - Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years JO - BMC Health Serv Res VL - 8 UR - https://doi.org/10.1186/1472-6963-8-50 DO - 10.1186/1472-6963-8-50 ID - Andersson2008 ER - TY - JOUR AU - Andersson, K. AU - Bergstrom, G. AU - Petzold, M. G. AU - Carlsten, A. PY - 2007 DA - 2007// TI - Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals JO - Health Pol (Amsterdam, Netherlands) VL - 81 UR - https://doi.org/10.1016/j.healthpol.2006.07.005 DO - 10.1016/j.healthpol.2006.07.005 ID - Andersson2007 ER - TY - JOUR AU - Wettermark, B. AU - Godman, B. AU - Andersson, K. AU - Gustafsson, L. L. AU - Haycox, A. AU - Bertele, V. PY - 2008 DA - 2008// TI - Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe JO - PharmacoEconomics VL - 26 UR - https://doi.org/10.2165/00019053-200826070-00001 DO - 10.2165/00019053-200826070-00001 ID - Wettermark2008 ER - TY - JOUR AU - Banahan, B. F. AU - Kolassa, E. M. PY - 1997 DA - 1997// TI - A Physician Survey on Generic Drugs and Substitution of Critical Dose Medications JO - Arch Intern Med VL - 157 UR - https://doi.org/10.1001/archinte.1997.00440390066010 DO - 10.1001/archinte.1997.00440390066010 ID - Banahan1997 ER - TY - JOUR AU - Kirking, D. M. AU - Gaither, C. A. AU - Ascione, F. J. AU - Welage, L. S. PY - 2001 DA - 2001// TI - Physicians’ individidual and organizational views on generic medications JO - J Am Pharm Assoc VL - 41 UR - https://doi.org/10.1016/S1086-5802(16)31306-7 DO - 10.1016/S1086-5802(16)31306-7 ID - Kirking2001 ER - TY - JOUR AU - Shrank, W. H. AU - Stedman, M. AU - Ettner, S. L. AU - DeLapp, D. AU - Dirstine, J. AU - Brookhart, M. A. AU - Fischer, M. A. AU - Avorn, J. AU - Asch, S. M. PY - 2007 DA - 2007// TI - Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use JO - J Gen Intern Med VL - 22 UR - https://doi.org/10.1007/s11606-007-0284-3 DO - 10.1007/s11606-007-0284-3 ID - Shrank2007 ER - TY - JOUR AU - Feely, J. AU - McGettigan, P. AU - O'Shea, B. AU - Chan, R. AU - McManus, J. PY - 1997 DA - 1997// TI - Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: Prescribers’ concerns JO - Ir Med J VL - 90 ID - Feely1997 ER - TY - BOOK AU - Murphy, M. B. PY - 1997 DA - 1997// TI - Review of Indicative Drug Target Savings Scheme. In: Review of Indicative Drug Target Savings Scheme PB - Health Service Executive CY - Lenus website ID - Murphy1997 ER - TY - STD TI - Practice Managers Manual.http://www.lenus.ie/hse/bitstream/10147/51033/1/PracticeManagersBook08.pdf, UR - http://www.lenus.ie/hse/bitstream/10147/51033/1/PracticeManagersBook08.pdf ID - ref126 ER - TY - JOUR AU - Walley, T. AU - Murphy, M. AU - Codd, M. AU - Johnston, Z. AU - Quirke, T. PY - 2000 DA - 2000// TI - Effects of a monetary incentive on primary care prescribing in Ireland: changes in prescribing patterns in one health board 1990–1995 JO - Pharmacoepidemiol Drug Saf VL - 9 UR - https://doi.org/10.1002/pds.544 DO - 10.1002/pds.544 ID - Walley2000 ER - TY - STD TI - Primary care: a new direction.http://www.dohc.ie/publications/pdf/primcare.pdf?direct=1, UR - http://www.dohc.ie/publications/pdf/primcare.pdf?direct=1 ID - ref128 ER - TY - JOUR AU - Harris, C. M. AU - Scrivener, G. PY - 1996 DA - 1996// TI - Fundholders' Prescribing Costs: The First Five Years JO - BMJ: Brit Med J VL - 313 UR - https://doi.org/10.1136/bmj.313.7071.1531 DO - 10.1136/bmj.313.7071.1531 ID - Harris1996 ER - TY - JOUR AU - Pope, N. D. PY - 2009 DA - 2009// TI - Generic Substitution of Narrow Therapeutic Index Drugs JO - US Pharmacist VL - 34 ID - Pope2009 ER - TY - JOUR AU - Okechukwu, I. AU - Bennett, K. AU - Feely, J. PY - 2006 DA - 2006// TI - General practitioners’ ranking of evidence-based prescribing quality indicators: a comparative study with a prescription database JO - Br J Clin Pharmacol VL - 62 UR - https://doi.org/10.1111/j.1365-2125.2006.02621.x DO - 10.1111/j.1365-2125.2006.02621.x ID - Okechukwu2006 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/2050-6511/14/1/prepub UR - http://www.biomedcentral.com/2050-6511/14/1/prepub ID - ref132 ER -